By Kira Peikoff, New York Times
Published on December 30, 2013
See full article here

Excerpt: “I like to plan ahead; that much I knew about myself before I plunged into exploring my genetic code. I’m a healthy 28-year-old woman, but some nasty diseases run in my family: coronary heart disease, rheumatoid arthritis, Alzheimer’s and breast cancer. So I decided to read the tea leaves of my DNA. I reasoned that it was worth learning painful information if it might help me avert future illness. Like others, I turned to genetic testing, but I wondered if I could trust the nascent field to give me reliable results. In recent years, a handful of studies have found substantial variations in the risks for common diseases predicted by direct-to-consumer companies. I set out to test the tests: Could three of them agree on me”